maculogix_logo

While there is a growing array of treatment options for age-related macular degeneration (AMD), there is currently no practical, low-cost method for detecting AMD at the early stages. MacuLogix, Inc. is developing a simple, cost-effective diagnostic tool for the early detection of AMD. Called AdaptDX, the device is based on dark adaptation, the transition from being light-adapted to being dark-adapted.

CEO
John Edwards

Location
Middletown, PA

  • The Funding Process

    The Funding Process

    The Life Sciences Greenhouse of Central Pennsylvania provides investment funding up to $1 million in milestone-driven convertible…

    Read more
  • Our Resource Center

    tomb2

    It’s a familiar scenario. You hear about a discovery that could lead to the cure for this disease or that debilitating…

    Read more
  • The 'PA' in LSGPA

    tomb3

    The Life Sciences Greenhouse of Central Pennsylvania’s 42-county service area contains more than 60 institutions of higher …

    Read more